J V Lafuente Selected Research

J V Lafuente Research Topics

5	Parkinson Disease (Parkinson's Disease) 01/2018 - 10/2015
5	Glioma (Gliomas) 01/2010 - 01/2000
3	Neoplasms (Cancer) 01/2010 - 09/2000
2	Brain Injuries (Brain Injury) 04/2006 - 01/2002
1	Neurodegenerative Diseases (Neurodegenerative Disease) 12/2016
1	Traumatic Brain Injuries (Traumatic Brain Injury) 06/2013
1	Cognitive Dysfunction 06/2013
1	Alzheimer Disease (Alzheimer's Disease) 12/2010
1	Brain Edema (Cerebral Edema) 01/2010
1	Wounds and Injuries (Trauma) 01/2010
1	Oligodendroglioma 01/2007
1	Brain Neoplasms (Brain Tumor) 09/2000
1	Astrocytoma (Pilocytic Astrocytoma) 09/2000
1	Glioblastoma (Glioblastoma Multiforme) 09/2000
1	Aneuploidy (Aneuploid) 01/2000
1	Hypoxia (Hypoxemia) 01/2000

5	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 06/2013 - 01/2002
3	Nerve Growth Factors (Neurotrophins)IBA 01/2018 - 10/2015
2	Proliferating Cell Nuclear Antigen (PCNA)IBA 09/2000 - 01/2000
2	DNA (Deoxyribonucleic Acid)IBA 09/2000 - 01/2000
1	cerebrolysinIBA 01/2018
1	Neuroprotective AgentsIBA 01/2018
1	Therapeutic UsesIBA 12/2017
1	Oxidopamine (6 Hydroxydopamine)IBA 12/2017
1	ChitosanIBA 12/2016
1	LipidsIBA 12/2016
1	Glial Cell Line-Derived Neurotrophic Factor (GDNF)IBA 12/2016
1	Advanced Glycation End ProductsIBA 12/2010
1	OccludinIBA 01/2010
1	Nitric Oxide Synthase Type III (Endothelial Nitric Oxide Synthase)IBA 01/2010
1	GadoliniumIBA 01/2009
1	Coloring Agents (Dyes)IBA 01/2009
1	Proteins (Proteins, Gene)FDA Link 01/2007
1	Ethylnitrosourea (N-Ethyl-N-nitrosourea)IBA 01/2007
1	Vascular Endothelial Growth Factor Receptor-2 (Vascular Endothelial Growth Factor Receptor 2)IBA 04/2006
1	LectinsIBA 04/2006
1	Complement System Proteins (Complement)IBA 09/2000
1	Biological ProductsIBA 09/2000
1	Bromodeoxyuridine (BrdU)IBA 01/2000
1	Nitric Oxide Synthase (NO Synthase)IBA 01/2000

1	Intranasal Administration 12/2016
1	Therapeutics 12/2016